Login to Your Account



In-Licensing Experts

Hua exploits in-licensing opportunities, focuses on unmet needs in China

By Shannon Ellis
Staff Writer

Thursday, January 2, 2014

SHANGHAI – In 2011 Shanghai-based Hua Medicine Ltd. made headlines in China as a start-up R&D biotech flush with a $50 million commitment from venture capital investors and a crew of talented veterans as founders and board members.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription